Evidence map›Paper›PMID 25064463›Full record

ArticleExperimental cell research2015

TGFβ loss activates ADAMTS-1-mediated EGF-dependent invasion in a model of esophageal cell invasion.

Grégoire F Le Bras, Chase Taylor, Rainelli B Koumangoye, Frank Revetta, Holli A Loomans, Claudia D Andl

Open access · greenAbstract read
In one paragraph

Article in Experimental cell research, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
1.4field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 32 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Transforming growth factor-β1 and diabetic nephropathy.American journal of physiology. Renal physiology · 2016
    Review
  13. Article
  14. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Grégoire F Le BrasDepartment of Surgery, Vanderbilt University, Nashville, TN, USA.
Chase TaylorDepartment of Surgery, Vanderbilt University, Nashville, TN, USA.
Rainelli B KoumangoyeDepartment of Surgery, Vanderbilt University, Nashville, TN, USA.
Frank RevettaDepartment of Pathology, Vanderbilt University, Nashville, TN, USA.
Holli A LoomansDepartment of Cancer Biology, Vanderbilt University, Nashville, TN, USA.
Claudia D AndlDepartment of Surgery, Vanderbilt University, Nashville, TN, USA; Department of Cancer Biology, Vanderbilt University, Nashville, TN, USA; Department of Vanderbilt Ingram Cancer Center, Vanderbilt University, Nashville, TN, USA. Electronic address: claudia.andl@vanderbilt.edu.
Vanderbilt University · US

Funding

Tumor Immunology and Microenvironment Research ProgramP30CA068485 · NCI · VANDERBILT UNIVERSITY MEDICAL CENTER · PI MATTHEW J TYSKA · 1995 to 2026
$172.8M
The Vanderbilt Institute for Clinical and Translational Research (VICTR)UL1TR000445 · NCATS · VANDERBILT UNIVERSITY MEDICAL CENTER · PI BERNARD, GORDON RAPHAEL · 2012 to 2016
$41.4M
Translational Analysis CoreP30DK058404 · NIDDK · VANDERBILT UNIVERSITY MEDICAL CENTER · PI RICHARD M. PEEK · 2002 to 2026
$29.9M
MULTIDISCIPLINARY BASIC RESEARCH TRAINING IN CANCERT32CA009592 · NCI · VANDERBILT UNIVERSITY · PI Justin M Balko, Julie A Rhoades (Sterling) · 1987 to 2026
$10.4M
The role of Activin A signaling in esophageal cell invasionR01DK094900 · NIDDK · VANDERBILT UNIVERSITY · PI ANDL, CLAUDIA D · 2012 to 2016
$1.6M
Mechanisms of epithelial-mesenchymal crosstalk during esophageal cell invasionR03DK091491 · NIDDK · VANDERBILT UNIVERSITY · PI ANDL, CLAUDIA D · 2012 to 2013
$153k
NCATS NIH HHS UL1 TR000445NCATS NIH HHS UL1TR000445NCI NIH HHS P30 CA068485NCI NIH HHS P30-CA068485NCI NIH HHS T32 CA009592NCI NIH HHS T32-CA009593NIDDK NIH HHS DK094900NIDDK NIH HHS P30 DK058404NIDDK NIH HHS P30-DK058404NIDDK NIH HHS R01 DK094900NIDDK NIH HHS R03 DK091491
6 · The paper itself

Abstract

The TGFβ signaling pathway is essential to epithelial homeostasis and is often inhibited during progression of esophageal squamous cell carcinoma. Recently, an important role for TGFβ signaling has been described in the crosstalk between epithelial and stromal cells regulating squamous tumor cell invasion in mouse models of head-and-neck squamous cell carcinoma (HNSCC). Loss of TGFβ signaling, in either compartment, leads to HNSCC however, the mechanisms involved are not well understood. Using organotypic reconstruct cultures (OTC) to model the interaction between epithelial and stromal cells that occur in dysplastic lesions, we show that loss of TGFβ signaling promotes an invasive phenotype in both fibroblast and epithelial compartments. Employing immortalized esophageal keratinocytes established to reproduce common mutations of esophageal squamous cell carcinoma, we show that treatment of OTC with inhibitors of TGFβ signaling (A83-01 or SB431542) enhances invasion of epithelial cells into a fibroblast-embedded Matrigel/collagen I matrix. Invasion induced by A83-01 is independent of proliferation but relies on protease activity and expression of ADAMTS-1 and can be altered by matrix density. This invasion was associated with increased expression of pro-inflammatory cytokines, IL1 and EGFR ligands HB-EGF and TGFα. Altering EGF signaling prevented or induced epithelial cell invasion in this model. Loss of expression of the TGFβ target gene ROBO1 suggested that chemorepulsion may regulate keratinocyte invasion. Taken together, our data show increased invasion through inhibition of TGFβ signaling altered epithelial-fibroblasts interactions, repressing markers of activated fibroblasts, and altering integrin-fibronectin interactions. These results suggest that inhibition of TGFβ signaling modulates an array of pathways that combined promote multiple aspects of tumor invasion.

Indexed as

Cell MovementADAM ProteinsADAMTS1 ProteinCarcinoma, Squamous CellCell Line, TumorCell ProliferationEsophageal NeoplasmsFibroblastsHeparin-binding EGF-like Growth FactorHumansInterleukin-1KeratinocytesNerve Tissue ProteinsReceptors, ImmunologicReceptors, Transforming Growth Factor betaRoundabout ProteinsADAM ProteinsADAMTS1 ProteinADAMTS1 protein, humanHeparin-binding EGF-like Growth FactorInterleukin-1Nerve Tissue ProteinsReceptors, ImmunologicReceptors, Transforming Growth Factor betaRoundabout ProteinsTransforming Growth Factor alphaTransforming Growth Factor betaADAMTS-1Cell matrix interactionESCCInvasionMMP14

Identifiers

PMID25064463
PMCPMC4267897
OpenAlexW2072110656

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.